Beam Therapeutics Stock Price on November 22, 2024
| BEAM Stock | USD 26.65 1.60 6.39% |
Below is the normalized historical share price chart for Beam Therapeutics extending back to February 06, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Beam Therapeutics stands at 26.65, as last reported on the 26th of November, with the highest price reaching 26.90 and the lowest price hitting 25.59 during the day.
If you're considering investing in Beam Stock, it is important to understand the factors that can impact its price. As of now, Beam Stock is not too volatile. Beam Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0292, which signifies that the company had a 0.0292% return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for Beam Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Beam Therapeutics' mean deviation of 3.12, and Risk Adjusted Performance of 0.0299 to double-check if the risk estimate we provide is consistent with the expected return of 0.12%.
At this time, Beam Therapeutics' Total Stockholder Equity is very stable compared to the past year. As of the 26th of November 2024, Other Stockholder Equity is likely to grow to about 2.3 B, while Liabilities And Stockholders Equity is likely to drop about 794.1 M. . At this time, Beam Therapeutics' Price Book Value Ratio is very stable compared to the past year. As of the 26th of November 2024, Price To Book Ratio is likely to grow to 2.25, while Price Earnings Ratio is likely to drop (16.64). Beam Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 6th of February 2020 | 200 Day MA 26.7481 | 50 Day MA 24.5148 | Beta 1.862 |
Beam |
Sharpe Ratio = 0.0292
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | BEAM | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.27 actual daily | 38 62% of assets are more volatile |
Expected Return
| 0.12 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Beam Therapeutics is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Beam Therapeutics by adding it to a well-diversified portfolio.
Price Book 2.6213 | Enterprise Value Ebitda (7.03) | Price Sales 5.9326 | Shares Float 64.8 M | Wall Street Target Price 49.2 |
Beam Therapeutics Main Headline on 22nd of November 2024
Acquisition by Walsh Kathleen E of 16532 shares of Beam Ther... by Walsh Kathleen E
Filed transaction by Beam Therapeutics Director. Grant, award or other acquisition pursuant to Rule 16b-3
Beam Therapeutics Valuation on November 22, 2024
It is possible to determine the worth of Beam Therapeutics on a given historical date. On November 22, 2024 Beam was worth 23.6 at the beginning of the trading date compared to the closed value of 25.05. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Beam Therapeutics stock. Still, in general, we apply an absolute valuation method to find Beam Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Beam Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Beam Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 24.53 | 24.71 | 23.33 | 23.58 | 1,010,234 | |
11/22/2024 | 23.60 | 25.43 | 23.18 | 25.05 | 1,187,273 |
| 25.94 | 26.90 | 25.59 | 26.65 | 1,217,320 |
| Backtest Beam Therapeutics | | | Beam Therapeutics History | | | Beam Therapeutics Valuation | Previous | Next |
Beam Therapeutics Trading Date Momentum on November 22, 2024
| On November 25 2024 Beam Therapeutics was traded for 26.65 at the closing time. The top price for the day was 26.90 and the lowest listed price was 25.59 . The trading volume for the day was 1.2 M. The trading history from November 25, 2024 was a factor to the next trading day price boost. The overall trading delta against the next closing price was 6.39% . The overall trading delta against the current closing price is 3.55% . |
Beam Therapeutics Fundamentals Correlations and Trends
By evaluating Beam Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Beam Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Beam financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Beam Therapeutics Stock history
Beam Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Beam is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Beam Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Beam Therapeutics stock prices may prove useful in developing a viable investing in Beam Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 77.2 M | 56.2 M | |
| Net Loss | -234.2 M | -245.9 M |
Beam Therapeutics Quarterly Net Working Capital |
|
Beam Therapeutics Stock Technical Analysis
Beam Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Beam Therapeutics Period Price Range
Low | November 26, 2024
| High |
0.00 | 0.00 |
Beam Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Beam Therapeutics November 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Beam Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Beam Therapeutics shares will generate the highest return on investment. By undertsting and applying Beam Therapeutics stock market strength indicators, traders can identify Beam Therapeutics entry and exit signals to maximize returns
Beam Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Beam Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Beam Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Beam to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0299 | |||
| Jensen Alpha | (0.29) | |||
| Total Risk Alpha | (0.56) | |||
| Sortino Ratio | (0) | |||
| Treynor Ratio | 0.0337 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Beam Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. To learn how to invest in Beam Stock, please use our How to Invest in Beam Therapeutics guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Beam Therapeutics. If investors know Beam will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Beam Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.58) | Revenue Per Share 4.273 | Quarterly Revenue Growth (0.17) | Return On Assets (0.09) | Return On Equity (0.18) |
The market value of Beam Therapeutics is measured differently than its book value, which is the value of Beam that is recorded on the company's balance sheet. Investors also form their own opinion of Beam Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Beam Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Beam Therapeutics' market value can be influenced by many factors that don't directly affect Beam Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Beam Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Beam Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Beam Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.